ABSTRACT
Immune reconstitution inflammatory syndrome (IRIS) in HIV-infected subjects initiating antiretroviral therapy most commonly involves new or worsening manifestations of previously subclinical or overt infectious diseases. Reports of non-infectious IRIS are much less common but represent important diagnostic and treatment challenges. We report on a 34-year-old HIV-infected male patient with no history of gout who developed acute gouty arthritis in a single joint one month after initiating highly active antiretroviral therapy.
Subject(s)
Antiretroviral Therapy, Highly Active/adverse effects , Arthritis, Gouty/chemically induced , HIV Infections/drug therapy , Immune Reconstitution Inflammatory Syndrome , Acute Disease , Adult , Humans , MaleABSTRACT
Immune reconstitution inflammatory syndrome (IRIS) in HIV-infected subjects initiating antiretroviral therapy most commonly involves new or worsening manifestations of previously subclinical or overt infectious diseases. Reports of non-infectious IRIS are much less common but represent important diagnostic and treatment challenges. We report on a 34-year-old HIV-infected male patient with no history of gout who developed acute gouty arthritis in a single joint one month after initiating highly active antiretroviral therapy.
A síndrome inflamatória da reconstituição imune (IRIS) observada quando do início da terapia antirretroviral em indivíduos com infecção pelo HIV envolve mais comumente manifestações novas ou piora clínica de desordens infecciosas, previamente subclínicas ou não. Muito mais raras são as descrições de casos de IRIS de natureza não-infecciosa, embora representem importantes desafios ao diagnóstico e tratamento. Neste relato descrevemos um paciente HIV-positivo do sexo masculino, de 34 anos, sem antecedentes de gota e que desenvolveu monoartrite de gota um mês após início de terapia antirretroviral de alta atividade.
Subject(s)
Adult , Humans , Male , Antiretroviral Therapy, Highly Active/adverse effects , Arthritis, Gouty/chemically induced , HIV Infections/drug therapy , Immune Reconstitution Inflammatory Syndrome , Acute DiseaseABSTRACT
A infecção pelo vírus da imunodeficiência humana atinge o Sistema Nervoso Central nos estágios iniciais, causando manifestações neuropsicológicas. Com o objetivo de estudar o desempenho de indivíduos infectados por este vírus em relação às funções cognitivas, foram avaliados 20 pacientes com contagem de linfócitos CD4+ acima de 200 células/mm³, utilizando-se a Escala de Inteligência Wechsler para Adultos. Destes, cinco (25 por cento) eram do sexo masculino e 15 (75 por cento) do sexo feminino, com média de idade de 39,65 desvio-padrão de 10,15 anos. A contagem média de linfócitos CD4+ foi 467,20 desvio-padrão de 215,45 células/mm?. Dentre quatorze pacientes que fizeram uso de terapia antirretroviral de alta atividade foi observado um caso com desempenho das funções cognitivas atenção e aprendizagem muito abaixo da média; os demais (n=13) tiveram desempenho dentro da média. Por meio da Escala de Inteligência Wechsler para Adultos foi possível detectar desempenho abaixo do nível médio do funcionamento cognitivo em indivíduos com resultado positivo para vírus da imunodeficiência humana, mesmo em vigência de terapia antirretroviral de alta atividade.(AU)
In its early stages, HIV-1 infection involves the Central Nervous System causing neuropsychological manifestations. With the aim of studying the cognitive functions in HIV-1-infected patients, a total of 20 patients infected with HIV-1 with CD4+ lymphocyte count >200 cells/mm³ were studied in accordance with the Wechsler Adult Intelligence Scale (WAIS-III). The present study comprised 20 patients, 5 (25 percent) male and 15 (75 percent) female, with a mean age of 39.65 and standard deviation of 10.15 years. The mean CD4+ lymphocyte count was 467.20 with a standard deviation of 215.45 cells/mm³. Amongst the 14 patients who received highly active anti-retroviral therapy (HAART), we noted 1 case in which the performance of the cognitive functions, attention span and learning, was considered to be very low according to WAIS-III, and the remaining (n=13) patients who were treated with HAART demonstrated a performance that was not considered to be outside of the WAIS-III mean. By using WAIS-III testing, it was possible to detect performance of the cognitive functions considered to be very low in HIV-1 infected individuals, even with those receiving HAART.(AU)
Subject(s)
Humans , Neuropsychology , Cognition Disorders , HIV-1ABSTRACT
A infecção pelo vírus da imunodeficiência humana atinge o Sistema Nervoso Central nos estágios iniciais, causando manifestações neuropsicológicas. Com o objetivo de estudar o desempenho de indivíduos infectados por este vírus em relação às funções cognitivas, foram avaliados 20 pacientes com contagem de linfócitos CD4+ acima de 200 células/mm³, utilizando-se a Escala de Inteligência Wechsler para Adultos. Destes, cinco (25 por cento) eram do sexo masculino e 15 (75 por cento) do sexo feminino, com média de idade de 39,65 desvio-padrão de 10,15 anos. A contagem média de linfócitos CD4+ foi 467,20 desvio-padrão de 215,45 células/mm?. Dentre quatorze pacientes que fizeram uso de terapia antirretroviral de alta atividade foi observado um caso com desempenho das funções cognitivas atenção e aprendizagem muito abaixo da média; os demais (n=13) tiveram desempenho dentro da média. Por meio da Escala de Inteligência Wechsler para Adultos foi possível detectar desempenho abaixo do nível médio do funcionamento cognitivo em indivíduos com resultado positivo para vírus da imunodeficiência humana, mesmo em vigência de terapia antirretroviral de alta atividade.
In its early stages, HIV-1 infection involves the Central Nervous System causing neuropsychological manifestations. With the aim of studying the cognitive functions in HIV-1-infected patients, a total of 20 patients infected with HIV-1 with CD4+ lymphocyte count >200 cells/mm³ were studied in accordance with the Wechsler Adult Intelligence Scale (WAIS-III). The present study comprised 20 patients, 5 (25 percent) male and 15 (75 percent) female, with a mean age of 39.65 and standard deviation of 10.15 years. The mean CD4+ lymphocyte count was 467.20 with a standard deviation of 215.45 cells/mm³. Amongst the 14 patients who received highly active anti-retroviral therapy (HAART), we noted 1 case in which the performance of the cognitive functions, attention span and learning, was considered to be very low according to WAIS-III, and the remaining (n=13) patients who were treated with HAART demonstrated a performance that was not considered to be outside of the WAIS-III mean. By using WAIS-III testing, it was possible to detect performance of the cognitive functions considered to be very low in HIV-1 infected individuals, even with those receiving HAART.
Subject(s)
Humans , Cognition Disorders , HIV-1 , NeuropsychologyABSTRACT
OBJECTIVE: Multiple sclerosis (MS) is an inflammatory disease characterized by multifocal areas of central nervous system (CNS) demyelination. Activation of coagulation factors and fibrin deposition are observed around CNS blood vessels in experimental autoimmune encephalomyelitis, an animal model of MS. Antithrombin (AT) is a potent anticoagulant with remarkable anti-inflammatory properties, and its inhibitory effects on coagulation and inflammation may play a role in the pathogenesis and clinical course of MS. We studied the association between plasma AT activity and clinical forms of MS. PATIENTS AND METHODS: A total of 69 patients, 37 with relapsing-remitting and 32 with secondary progressive MS, were included in the study. A control group (CG) of 34 normal subjects was also studied. Plasma AT activity (Stachrom ATIII) was quantified using a chromogenic activity assay with normal reference values ranging from 70% to 120% of AT activity. RESULTS: We found no difference between plasma AT levels in patients and those in CG. We also found no association of AT levels with activity of disease, duration of disease progression, level of neurological disability, and treatment. CONCLUSION: We found no association between plasma AT activity and RRMS or SPMS. It remains to be studied whether exists or not an association between abnormal plasma AT activity and other MS forms.
Subject(s)
Antithrombins/metabolism , Multiple Sclerosis, Chronic Progressive/blood , Adult , Disability Evaluation , Female , Humans , Male , Middle Aged , Multiple Sclerosis, Chronic Progressive/pathology , Reference Values , Thrombin/metabolismABSTRACT
Formas altamente agressivas de carcinoma cutâneo de células escamosas vêm sendo reconhecidas como uma importante complicação da infecção pelo HIV. Descrevemos o caso de um paciente do sexo masculino, de 59 anos, que se apresentou com uma lesão altamente agressiva de SCC na região do couro cabeludo, com destruição do osso parietal subjacente e curso clínico fulminante.
Subject(s)
Humans , Male , Middle Aged , Carcinoma, Squamous Cell , HIV Infections , Skin Neoplasms , Carcinoma, Squamous Cell , Fatal Outcome , Scalp , Skin NeoplasmsSubject(s)
Edema/chemically induced , HIV Infections/drug therapy , HIV Protease Inhibitors/adverse effects , Pyrimidinones/adverse effects , Ritonavir/adverse effects , Adult , HIV Protease Inhibitors/administration & dosage , Humans , Lopinavir , Male , Pyrimidinones/administration & dosage , Recurrence , Ritonavir/administration & dosageSubject(s)
Humans , Male , Adult , Edema , HIV Infections , HIV Protease Inhibitors , Ritonavir , Hand , HIV Protease Inhibitors , Recurrence , RitonavirABSTRACT
Unusually aggressive forms of cutaneous squamous cell carcinoma are being increasingly recognized as a complication of HIV infection. We report the case of a 59-year-old male patient with advanced HIV infection who presented with a highly aggressive SCC lesion over the scalp area with destruction of the underlying parietal bone and fulminant clinical progression.
Subject(s)
Carcinoma, Squamous Cell/pathology , HIV Infections/complications , Head and Neck Neoplasms/pathology , Scalp , Skin Neoplasms/pathology , Carcinoma, Squamous Cell/complications , Carcinoma, Squamous Cell/diagnostic imaging , Fatal Outcome , Head and Neck Neoplasms/complications , Head and Neck Neoplasms/diagnostic imaging , Humans , Male , Middle Aged , Neoplasm Invasiveness , Parietal Bone/pathology , Radiography , Skin Neoplasms/complications , Skin Neoplasms/diagnostic imagingSubject(s)
Edema/chemically induced , HIV Infections/complications , HIV Protease Inhibitors/adverse effects , HIV-1 , Pyrimidinones/adverse effects , Adult , Antiretroviral Therapy, Highly Active , HIV Infections/drug therapy , HIV Infections/immunology , HIV Infections/physiopathology , HIV Protease Inhibitors/therapeutic use , Humans , Lopinavir , Male , Middle Aged , Pyrimidinones/therapeutic useABSTRACT
The development of paradoxical clinical worsening following initiation of tuberculosis treatment may complicate the clinical course of both HIV-infected and uninfected patients. We report a severe manifestation of the so called paradoxical reaction to the treatment of tuberculosis that unmasked previously silent meningeal disease in a 34-year-old HIV-infected male patient.
Subject(s)
Anti-HIV Agents/adverse effects , Antitubercular Agents/adverse effects , Tuberculosis, Meningeal/diagnosis , Adult , Drug Interactions , Humans , Male , Tuberculosis, Meningeal/etiologyABSTRACT
The development of paradoxical clinical worsening following initiation of tuberculosis treatment may complicate the clinical course of both HIV-infected and uninfected patients. We report a severe manifestation of the so called paradoxical reaction to the treatment of tuberculosis that unmasked previously silent meningeal disease in a 34-year-old HIV-infected male patient.
